Cellebrite DI Ltd.
CLBT
$18.25
$0.975.61%
| Weiss Ratings | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.40 | |||
| Price History | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.49% | |||
| 30-Day Total Return | -23.96% | |||
| 60-Day Total Return | -8.20% | |||
| 90-Day Total Return | 0.55% | |||
| Year to Date Total Return | -15.74% | |||
| 1-Year Total Return | 53.75% | |||
| 2-Year Total Return | 211.97% | |||
| 3-Year Total Return | 203.66% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -34.30% | |||
| 52-Week Low % Change | 68.67% | |||
| Price | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $26.30 | |||
| 52-Week Low Price | $10.25 | |||
| 52-Week Low Price (Date) | Jun 04, 2024 | |||
| 52-Week High Price (Date) | Feb 06, 2025 | |||
| Valuation | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.77B | |||
| Enterprise Value | 3.30B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.17 | |||
| Earnings Per Share Growth | -32.46% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 12.60 | |||
| Price/Book (Q) | -89.35 | |||
| Enterprise Value/Revenue (TTM) | 12.08 | |||
| Price | $18.25 | |||
| Enterprise Value/EBITDA (TTM) | 67.25 | |||
| Enterprise Value/EBIT | 80.49 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 198.95M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 972 73 394 8000 | |||
| Address | -- | |||
| Website | www.cellebrite.com | |||
| Country | Israel | |||
| Year Founded | -- | |||
| Profitability | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $1.37 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | 24.82% | |||
| Earnings Growth (Q YOY) | 26.39% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | 32.59% | |||
| Balance Sheet | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 305.31M | |||
| Cash Per Share (Q) | $1.53 | |||
| Total Current Assets (Q) | 414.75M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -40.16M | |||
| Current Ratio (Q) | 1.748 | |||
| Book Value Per Share (Q) | -$0.19 | |||
| Total Assets (Q) | 556.58M | |||
| Total Current Liabilities (Q) | 237.23M | |||
| Total Debt (Q) | 11.68M | |||
| Total Liabilities (Q) | 596.74M | |||
| Total Common Equity (Q) | -40.16M | |||
| Cash Flow | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
